Healthcare and Medical Device

  The global   Veterinary API Market   is estimated to grow significantly. By 2028, it is projected to reach a value of USD 11.9 billion, showing a compound annual growth rate (CAGR) of 6.9% during the forecast period, starting from USD 8.5 billion in 2023 according to a new report by MarketsandMarkets™. The expansion of the Veterinary API Market is driven by various factors, including rising incidence of transboundary & zoonotic diseases, increasing animal population and pet ownership, and increasing disease control & disease prevention measures. Download an Illustrative overview:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=91801752 The Veterinary API Market is divided into three types based on synthesis types such as Chemical based API, Biological API, and Highly potent API. The Chemical based API segment accounted for the highest share of the global Veterinary API Market in 2022. Increasing Demand for Plasma-Derived Medicinal Products, Advance...

Adhesion Barrier Market in terms of revenue was estimated to be worth $0.7 billion in 2023 and is poised to reach $0.9 billion by 2028, growing at a CAGR of 7.4%. The main drivers promoting the development of this market are the rising number of surgeries and sports-related injuries, an increasing elderly population, and the rising awareness of adhesion formation and diseases associated with adhesions. Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=208132543 The prominent players operating in the adhesion barriers market are Baxter International (US), Johnson & Johnson (J&J) (US), and Becton, Dickinson and Company (US), Integra LifeSciences (US), Anika Therapeutics (US), Atrium Medical Corporation (US), FzioMed (US), MAST Biosurgery (Switzerland), Innocoll (Ireland), Betatech Medical (Turkey), CorMatrix Cardiovascular, Inc. (US), Terumo Corporation (Japan), BiosCompass (US), W.L.Gore & Associates (US), GUNZE Limited (Japan), ...

Mass Spectrometry Market   in terms of revenue was estimated to be worth $5.4 billion in 2023 and is poised to reach $7.8 billion by 2028, growing at a CAGR of 7.5% from 2023 to 2028 according to a new report by MarketsandMarkets™. The rise in advantages offered by mass spectrometry to be used in therapeutics is one of the major factors anticipated to boost market growth in the forecasting years. Download an Illustrative overview:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=437 Mass Spectrometry Market by Product (Instrument (Triple Quadrupole, Q-TOF, FTMS, Quadrupole, TOF), Services), Sample Preparation (LC-MS, GC-MS), Application (Omics, Clinical, Environmental), End User (Pharma, Academia, F&B) & Region – Forecasts to 2028 Mass Spectrometry Key Market Players: The mass spectrometry business is very competitive, with both established companies and newcomers competing for the same market share. As of 2022, the key players operating in the global mass spec...

Tissue Engineering Market  in terms of revenue was estimated to be worth $4.4 billion in 2023 and is poised to reach $8.9 billion by 2028, growing at a CAGR of 15.3% from 2023 to 2028 according to a new report by MarketsandMarkets™. The growing demand for innovative tissue engineering solutions for the treatment of chronic diseases and for repair and regeneration of tissues and technological developments such as 3D bioprinting is promoting the growth of the tissue engineering market. Download an Illustrative overview:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=34135173 Based on product type, the tissue engineering market has been segmented into scaffolds, tissue grafts, and other products. Tissue grafts are further categorized into allografts, autografts, xenografts, and synthetic grafts. In 2022, the scaffold segment accounted for the largest share of the tissue engineering market. Increasing research activities for the development of advanced solutions for the ...

Base Editing Market  in terms of revenue was estimated to be worth $270 million in 2023 and is poised to reach $549 million by 2028, growing at a CAGR of 15.2% from 2023 to 2028 according to a new report by MarketsandMarkets™. Growing interest in gene editing technologies, including base editing, has attracted substantial funding and investment from both public and private sources. This financial support is crucial for research and development efforts, accelerating the commercialization of base editing technologies. However, ethical & safety concerns are the factors restraining market growth. Download an Illustrative overview:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=21238371 Segments Covered Product & Service, Type, Targeted Base, Application, and End User Geographies Covered North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa Report Highlights Updated financial information / product portfolio of players Key Market Opport...